Dane Cheasley
Papers
1
Total Citations
13
H-Index
1
About
Dane Cheasley is a translational cancer researcher whose work focuses on low-grade serous ovarian carcinoma (LGSOC), a rare and understudied epithelial ovarian cancer with distinct molecular features. His major contributions include pioneering high-throughput drug screening to identify novel therapeutics for LGSOC, addressing a critical gap in treatment options for this patient population. His most-cited paper (2024, 13 citations) highlights the unique biology of LGSOC and the insufficiency of clinical trial data derived from more common ovarian cancers, underscoring the need for targeted therapies. Cheasley’s research has advanced understanding of LGSOC’s molecular landscape, offering hope for more effective, personalized treatments. His work is notable for its focus on a neglected cancer subtype, and his findings are shaping future clinical strategies. With growing citation impact, Cheasley is a rising voice in ovarian cancer research, bridging the gap between rare tumor biology and actionable therapeutics.
Research Focus
Key Achievements
Top Papers
- 1